Salvage Pembrolizumab Added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0378-y
Full Text
Open PDFAbstract
Available in full text
Date
July 11, 2018
Authors
Publisher
BMJ